ENBreast cancer chemotherapy in Germany is not for everyone: the decision follows tumour biology, not how big the tumour looks. With the diagnosis made and “chemotherapy” in the plan, two questions follow: is it really needed in your case, and how will it work in a foreign country?
This page explains who is offered chemotherapy for breast cancer in Germany, why it runs before or after surgery, how cycles work, how side effects are handled and how it fits around a trip. It gives no regimens or doses for self-treatment and promises no outcome. See also breast cancer treatment in Germany.
Who needs chemotherapy and who does not
Whether chemotherapy is needed depends on tumour biology: the hormone receptors (does the tumour respond to female hormones?), the HER2 protein, the Ki-67 index of cell division, the grade, tumour size and lymph nodes. In a hormone-sensitive tumour at low risk, anti-hormonal therapy rather than chemotherapy may be the backbone of treatment.
Where the border is unclear, German centres may test gene expression in the tumour tissue to judge whether chemotherapy adds benefit to anti-hormonal treatment. The test is meant only for such borderline cases, and the tumour board discusses ordering it.
In triple-negative and HER2-positive disease, chemotherapy is standard unless the tumour is very small, and in HER2-positive disease targeted antibodies are added: trastuzumab, plus pertuzumab for larger tumours or involved nodes. These different drugs work together: chemo hits all fast-dividing cells, healthy ones included, while the antibody blocks HER2 on cancer cells. Details are in the Krebsinformationsdienst material of the German Cancer Research Center (in German).
Before surgery or after
Breast cancer chemotherapy can run before or after the operation. Neoadjuvant chemotherapy comes first: it shrinks the tumour, can sometimes allow the breast to be conserved instead of removed and, most importantly, shows whether the tumour responds to the drugs.
Finding no tumour cells in the removed tissue after the course is a favourable sign; if residual disease remains, treatment after surgery may change. This is why aggressive subtypes in Germany, HER2-positive and triple-negative, more often get drugs first when the tumour exceeds two centimetres or nodes are involved; in triple-negative disease the guideline also recommends adding the immunotherapy drug pembrolizumab.
Adjuvant chemotherapy follows surgery when the tumour is out but the histology shows a meaningful risk of recurrence. In advanced disease the aim is to hold the disease and protect quality of life, so regimens change as things develop. For other diagnoses, see chemotherapy in Germany.
How a course is organised
Treatment runs in cycles: an infusion day, then a break for the blood counts to recover, usually around three weeks, or one week on a weekly schedule; at high risk the gaps are shorter. Many regimens give anthracyclines, then taxanes. The clinic’s written plan lists the dates.
The course is usually given in the oncology day unit; few patients need admission. Before the start a port may be placed under the skin near the collarbone, a small chamber whose catheter carries drugs into a large vein, sparing the arm veins; the ward explains how to handle it.
Between cycles the team checks blood counts before every infusion, the weight, which helps set the dose, and the heart with anthracyclines or HER2 drugs, which can weaken it. These checkpoints decide whether the next infusion goes ahead on the planned day.
Side effects and what is done about them
Side effects in Germany are handled in advance: nausea is prevented with drugs given with the chemotherapy. A sharp fall in white cells calls for injections that boost them, and a fever then means calling the ward immediately, not waiting for the morning.
Hair falls out with many regimens, but usually grows back, typically starting a few months after the course. Some clinics offer scalp cooling during infusions, though evidence on its benefit is mixed. The nurse explains care of the mouth, skin and nails before treatment starts.
What people forget to ask: fertility preservation is discussed before the first infusion, not after, as options narrow later. Fatigue accompanies the course and can take months to fade; manageable physical activity helps and is recommended during chemotherapy too. On recovery, see oncological rehabilitation in Germany.
Fitting the course around a trip to Germany
There are usually two options: the whole course in Germany, or starting here and continuing at home on the German plan with review visits. The choice depends on the regimen, the visa, the budget and whether an oncologist at home will run a German protocol.
Take away in writing the plan with dates and drugs, the port report, what to do with a fever and whom to call, and the follow-up schedule. Costs are explained on the page cost of breast cancer treatment in Germany; if radiotherapy follows chemotherapy, see breast cancer radiotherapy in Germany.
Frequently asked questions
How long does breast cancer chemotherapy take?
For early breast cancer, a chemotherapy course usually takes between 18 and 24 weeks, depending on the number of cycles and the gaps between them. In HER2-positive disease the antibodies continue afterwards, about a year in total. In a hormone-sensitive tumour, anti-hormonal treatment follows the course and lasts for years.
What happens if tumour remains after chemotherapy before surgery?
Treatment after surgery is changed or extended. In HER2-positive disease trastuzumab is replaced by trastuzumab emtansine, an antibody linked to a chemotherapy drug. In triple-negative disease capecitabine tablets are added, and with an inherited BRCA1 or BRCA2 mutation olaparib may be needed. The tumour board decides after the operation.
Can I get pregnant after breast cancer chemotherapy?
Yes. The German guideline says women should not be advised against pregnancy after breast cancer, whatever the hormone receptor status of the tumour. Chemotherapy can reduce fertility, in young women usually only for a time. That is why freezing eggs or ovarian tissue is discussed before the first infusion.
How AlenMed arranges chemotherapy in Germany
AlenMed reviews the histology and reports, matches an oncology department, books the tumour board, translates documents, sends a written estimate before the trip, arranges the visa invitation and provides interpreters for appointments and infusions. One example among the partners is Prof. Marc Thill, head of the clinic for gynaecology and gynaecological oncology at the Agaplesion Markus Krankenhaus in Frankfurt.
Plan ahead: how many weeks the course takes, where to stay between cycles, how to get documents in a readable language and how to arrange continuing treatment at home.
This material is for information and is not an offer. The regimen and the indication are decided by a doctor in person.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
